Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Net Income towards Common Stockholders (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$14.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 54.18% year-over-year to -$14.2 million, compared with a TTM value of -$4.2 million through Dec 2025, up 96.72%, and an annual FY2025 reading of -$958000.0, up 99.25% over the prior year.
  • Net Income towards Common Stockholders was -$14.2 million for Q4 2025 at Alignment Healthcare, down from $3.7 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $15.7 million in Q2 2025 and bottomed at -$57.0 million in Q4 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$31.3 million, with a median of -$36.2 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders tumbled 635.11% in 2021, then skyrocketed 165.21% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$47.8 million in 2021, then dropped by 19.15% to -$57.0 million in 2022, then rose by 17.13% to -$47.2 million in 2023, then surged by 34.23% to -$31.1 million in 2024, then soared by 54.18% to -$14.2 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for ALHC at -$14.2 million in Q4 2025, $3.7 million in Q3 2025, and $15.7 million in Q2 2025.